Thalomid Trademark Details

Thalomid was registered on Tuesday, December 30, 2008 and is currently owned by Celgene Corporation under the registration number 3554067 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Thursday, January 2, 2014, according to the United State Patent & Trademark Office
Word Mark Thalomid
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 77489356
Registration Number 3554067
Status Date Thursday, January 2, 2014
Filing Date Thursday, January 2, 2014
Registration Date Tuesday, December 30, 2008
Attorney Camille M. Miller

Correspondent

Camille M. Miller
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103

Case File Statements

Indication of Colors The color(s) black, white and red is/are claimed as a feature of the mark.
Description of Mark The mark consists of a red square bisected by a white swirl design. The word "THALOMID" appears in black letters to the right .
Goods & Services Pharmaceutical Preparations, Namely, Cytokine Inhibitory Drugs; Pharmaceutical Preparations for the Treatment of Certain Cancers; Pharmaceutical Preparations That Modulate the Immune System

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, June 6, 2008
First Use Anywhere Thursday, September 1, 2005
First Use In Commerce Thursday, September 1, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.